Ordaos
Latest round
- Seed
Last raised
- Aug 2022
Total raised
- $5M
Investors
- 5
About Ordaos
Based in New York, US, and founded in 2019, Ordaos, Inc. is the provider of life-saving treatment through its creation mini – protein. As of 2022 company is headed by its CEO David Longo. The company offers flagship solution miniPRO™ proteins that help in delivering safe and effective treatments. miniPRO™ proteins provide the power and performance of antibodies but can be easily scale-up, configured, and manufactured. Additionally, the firm also provides birth novel therapies that reduce the patient’s suffering, improve their health, and extend their life.
Who invested in Ordaos
5 investors across 1 round
See all investors in Ordaos
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Aug 25, 2022
Amount
$5M
Investors
Questions about Ordaos
Who invested in Ordaos?
Ordaos has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ordaos raised?
Ordaos has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ordaos last raise money?
Ordaos's most recent round on record is a Seed, in Aug 2022.
What does Ordaos do?
Based in New York, US, and founded in 2019, Ordaos, Inc.
Where is Ordaos headquartered?
Ordaos is headquartered in New York, US.
Which VCs invest in companies like Ordaos?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ordaos's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Ordaos? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.